ACI makes a series of recommendations to expedite the authorisation process for ingestible CBD products

Published: 10-Jan-2024

The ACI has called on the Food Standards Agency (FSA) and the Home Office to work together to resolve the outstanding issues stalling progress on British novel food applications

In a fresh bid to bring to a close the regulatory stalemate threatening an entire sector, the Association has produced a new white paper underlining the need for constructive engagement between the respective authorities. 

The paper draws on a wide-ranging consultation across the UK’s consumer cannabinoid industry to establish a clear and legal framework to safeguard the future of the sector.

Five years on from the European Commission’s declaration that ingestible products containing cannabinoids were to be considered as novel foods, and 4 years since the FSA followed suit, the future of thousands of products and an entire sector now hangs in the balance. 

Steve Moore, ACI cofounder, said: “Whilst the attempts by both the Home Office and the Food Standards Agency to allow CBD products to continue on the market is commendable, the processes have taken too long, become too confused and have not been sufficiently co-ordinated."

"The agency and the department should take account of the recommendations in this report. Together they provide a path to expedite the legal and regulation frameworks the industry has been crying out for and invested millions of pounds towards progress.” 

You may also like